HRA004597
Title:
Intergrated Multi-omics Sequencing Reveals Metabolic Reprograms in the Progression of ccRCC (WES))
Release date:
2023-06-25
Description:
100 samples from treatment-naive ccRCC patients and 50 matched normal adjacent tissues (NATs) were profiled with whole exon sequencing (WES), whole transcriptome sequencing (WTS), data-independent acquisition (DIA)-based proteome and untargeted metabolome technology to identify the general molecular characteristics of the TJ-RCC cohort. Single-nucleic RNA sequencing, single-nucleic multiome, spatial transcriptome and spatial metabolome were performed on part of these 100 tumors to detail the ITH inside ccRCC.
Data Accessibility:   
Controlled access Request Data
BioProject:
Study type:
Disease Study
Disease name:
clear cell renal cell carcinoma
Data Access Committee

For each controlled access study, there is a corresponding Data Access Committee(DAC) to determine the access permissions. Access to actual data files is not managed by NGDC.


DAC NO.:
DAC name:
DAC_KeChen
Contact person:
Ke Chen
Email:
shenke@hust.edu.cn
Description:
Wuhan Union Hospital, Huazhong University of Science and Technology
Individuals & samples
Submitter:   Ke Chen / shenke@hust.edu.cn
Organization:   Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Submission date:   2023-01-22
Requests:   6